DSE:RUPALILIFE

Rupali Life Insurance Company Limited announcements

325 Dhaka Stock Exchange announcements for Rupali Life Insurance Company Limited (RUPALILIFE) since 2009: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (20).

  1. Regarding revaluation of Fixed Assets of the company

    The company has informed that the Board of Directors of the company in its 187th Board Meeting held on November 01, 2023 at the registered office of the company has approved the revaluation of Fixed Assets of the company from Tk. 34,29,55,395 to Tk. 45,97,20,000 resulting a revaluation surplus of Tk. 11,67,64,605. The revaluation of the Fixed Assets of the company has been conducted by MRH DEY & Co, Chartered Accountants.

  2. Dividend Disbursement

    The Company has informed that it has disbursed the cash dividend for the year ended December 31, 2022 to the respective shareholders.

  3. (Q3 Un-audited): As per life revenue account of the company for July to September, 2023, excess of total expenses includ

    (Q3 Un-audited): As per life revenue account of the company for July to September, 2023, excess of total expenses including claims over total income (deficit) was BDT 334.81 million as against excess of total income over total expenses including claims (surplus) of BDT 7.60 million in the corresponding previous period of 2022. Whereas as per life revenue account of the company for January to September, 2023, (cont.)

  4. Q3 Financials

    (Continuation news of RUPALILIFE): excess of total expenses including claims over total income (deficit) was BDT 333.47 million as against excess of total income over total expenses including claims (surplus) of BDT 26.49 million in the corresponding previous period of 2022. Accordingly, Balance of Life Insurance Fund was BDT 4,734.48 million as on September 30, 2023 as against BDT 5,310.99 million as on September 30, 2022 resulting a net decrease of BDT 576.51 million. (end)

    The first part of this announcement is missing from the archive.
  5. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended September 30, 2023.

  6. Update of Information

    The company has requested the Concerned Brokerage House/DPs to provide them the statement (both of hard copy and soft copy) with details of their margin loan holders entitled to final dividend of 2022 on or before September 15, 2023. The Statement should include shareholders' name, BO ID no., client wise shareholding position, contact person etc. Please send soft copy to the email: [email protected]. Contact# 01847-133722

  7. Resumption after Record Date

    Trading of the shares of the company will resume on 20.08.2023.

  8. Suspension for Record Date

    Trading of the shares of the company will be suspended on record date i.e., 17.08.2023.

  9. Spot News

    Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 14.08.2023 to 16.08.2023 and trading of the shares will remain suspended on record date i.e., 17.08.2023.

  10. The auditor of the company has given the \"Qualified Opinion\" and \"Emphasis of Matter\" paragraphs in the Auditor\'s R

    The auditor of the company has given the \"Qualified Opinion\" and \"Emphasis of Matter\" paragraphs in the Auditor\'s Report for the year ended December 31, 2022. To view the details, please visit: https://www.dsebd.org/assets/pdf/RupaliLifeInsuranceCompany.pdf

  11. (Q2 Un-audited): As per life revenue account of the company for April to June, 2023, excess of total claims and expenses

    (Q2 Un-audited): As per life revenue account of the company for April to June, 2023, excess of total claims and expenses over total income (deficit) was BDT 4.59 million as against excess of total income over total claims and expenses (surplus) of BDT 3.52 million in the corresponding previous period of 2022. Whereas as per life revenue account of the company for January to June, 2023, excess of total income over total claims and expenses (surplus) (cont.)

  12. Q1 Financials

    (Q1 Un-audited): As per life revenue account of the company for January to March, 2023, excess of total income over total claims and expenses (surplus) was BDT 5.93 million as against excess of total income over total claims and expenses (surplus) of BDT 15.37 million in the corresponding previous period of 2022. Accordingly, Balance of Life Insurance Fund as on March 31, 2023 was BDT 5,073.88 million as against BDT 5,299.88 million as on March 31, 2022 resulting a net decrease of BDT 226.00 million.

  13. Dividend Declaration

    The Board of Directors has recommended 11% Cash Dividend for the year ended December 31, 2022. Date of AGM: 26.09.2023, Time: 10:00 AM, Venue: Digital Platform. Record Date: 17.08.2023.

  14. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (24.07.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.

  15. Q2 Financials

    (Continuation news of RUPALILIFE): was BDT 1.34 million as against excess of total income over total claims and expenses (surplus) of BDT 18.89 million in the corresponding previous period of 2022. Accordingly, Balance of Life Insurance Fund as on June 30, 2023 was BDT 5,069.29 million as against BDT 5,303.39 million as on June 30, 2022 resulting a net decrease of BDT 234.10 million. (end)

    The first part of this announcement is missing from the archive.
  16. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 23, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended March 31, 2023 and Second Quarter (Q2) period ended June 30, 2023 respectively.

  17. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 23, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2022.

  18. Query Response

    In response to a DSE query dated July 05, 2023, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike of shares.

  19. Query Response

    In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.

  20. Query Response

    In response to a DSE query, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.